A fresh look at the concept of Genus Epidemicus: findings from the Clificol Project

The Clificol® COVID-19 Support Project is an innovative international data collection project aimed at tackling some of the core questions in homeopathy, including the notion of Genus Epidemicus. Aims:To shed some light on the notion of Genus Epidemicus in the context of this infection. Going beyond that, the project aims to use these data to tackle more fundamental questions, such as the role of symptoms and rubrics in treatment individualisation. Methodology:This online multi-national data-collection project is supported by the ECH, ECCH, ICH, HRI, LMHI, and other professional associations. The collected data includes demographic information, severity, conventional diagnosis and treatment, presenting symptoms as well as the remedies prescribed. The outcome of treatment was tracked using the ORIDL scale. The concept of Genus Epidemicus, including the role of treatment individualisation, was investigated by analysing whether presenting symptoms cluster into distinct groups (K-Means clustering approach). The symptom data originating from China was obtained using a questionnaire. Results and discussion: 20 Chinese practioners collected 359 cases, primarily in the first half of 2020 (766 consultations, 363 prescriptions). The cluster analysis found two to be the optimum number of clusters. These two symptomatic clusters had a high overlap with the two most commonly prescribed remedies in that population: In cluster 1 there were 297 prescriptions, 95.6% of which were Gelsemium sempervirens, incluster 2, there were 61 prescriptions, 95.1% of which were Bryonia alba. Under the assumption of a single genus epidemicuswe would expect to see a single cluster of symptoms. The data from the Chinese population were not compatible with this assumption. Conclusion:This was the first study that investigated the notion of Genus Epidemicus by using modern statistical techniques. These analyses identified at least two distinct symptom pictures. The notion of a single COVID-19 Genus Epidemicus did not apply to this population.

Clinical Trial Of Homoeopathic Genus Epidemicus 'Arsenic Alba' As A Prophylactic During Pandemic Of Covid 19 In India At Dr. V. H. Dave Homoeopathic Medical Collage

Background:The objective was to assessthe usefulness of Homoeopathic genus epidemics (Arsenic alba30C) for the prevention of Covid 19 during its pandemic outbreak in the state of Gujrat District Anand, City Anand, India.Materials and Methods:A non-randomized, clinical trial was conducted in Anand city for prevention of Covid 19 during the pandemic outbreak in June 2020 to December 2020.Arsenic alba30C was randomly administered to 1133 participants. Healthy participants (absence of fever, runny nose, cough etc., but comorbidity like DM & HTN included) were eligible for the study (Arsenic alba30 Cn=1133). Monthly follow-up was done for 6 months. Infection rate in the study groups was analyzed and compared by use of cluster analysis.Results:The findings showed that only 4 persons out of1133 persons ofArsenic alba30 C group suffered from Covid 19. Cluster analysis showed significant prevention during Pandemic without any vaccine or other medications. [Incidence rate = 0.35%].Conclusion:Arsenic alba30C as genus epidemics is much better in decreasing the incidence of Covid 19 in cluster in Anand. The efficacy ofgenus epidemicusneeds to be replicated in different areas.